Literature DB >> 16219697

Method for targeting protein destruction by using a ubiquitin-independent, proteasome-mediated degradation pathway.

Shu-ichi Matsuzawa1, Michael Cuddy, Toru Fukushima, John C Reed.   

Abstract

With the euchromatic portion of several mammalian genomes now sequenced, emphasis has turned to ascertaining the functions of gene products. A method for targeting destruction of selected proteins in mammalian cells is described, based on the ubiquitin-independent mechanism by which ornithine decarboxylase (ODC) is degraded by the 26S proteasome in collaboration with antizyme (AZ). We show that expressing whole proteins, protein domains, or peptide ligands fused to the N terminus of ODC promotes proteasome-dependent degradation of these chimeric fusion proteins and their interacting cellular target proteins. Moreover, the degradation of the interacting (targeted) protein depends on coexpression of AZ in about half of cases, providing an inducible switch for triggering the degradation process. By using 12 pairs of interacting proteins for testing, direct comparisons with several alternative strategies for achieving targeted protein destruction based on the concept of induced ubiquitination revealed advantages of the ODC/AZ system, which does not require posttranslational attachment of ubiquitin to target proteins. As proof of concept, the ODC/AZ system was used to ablate expression of specific endogenous proteins (e.g., TRAF6; Rb), and was shown to create the expected lesions in cellular pathways that require these proteins. Altogether, these findings reveal a strategy for achieving targeted destruction of cellular proteins, thus providing an additional tool for revealing the cellular phenotypes of gene products.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219697      PMCID: PMC1257734          DOI: 10.1073/pnas.0507512102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Regulation of cellular polyamines by antizyme.

Authors:  P Coffino
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex.

Authors:  B A Schulman; A C Carrano; P D Jeffrey; Z Bowen; E R Kinnucan; M S Finnin; S J Elledge; J W Harper; M Pagano; N P Pavletich
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  Targeted modification and transportation of cellular proteins.

Authors:  P Colas; B Cohen; P Ko Ferrigno; P A Silver; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

Authors:  S I Matsuzawa; J C Reed
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

5.  Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Authors:  K M Sakamoto; K B Kim; A Kumagai; F Mercurio; C M Crews; R J Deshaies
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 6.  Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death.

Authors:  R H Arch; R W Gedrich; C B Thompson
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

7.  Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.

Authors:  Ning Zheng; Brenda A Schulman; Langzhou Song; Julie J Miller; Philip D Jeffrey; Ping Wang; Claire Chu; Deanna M Koepp; Stephen J Elledge; Michele Pagano; Ronald C Conaway; Joan W Conaway; J Wade Harper; Nikola P Pavletich
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

8.  Distinct molecular mechanism for initiating TRAF6 signalling.

Authors:  Hong Ye; Joseph R Arron; Betty Lamothe; Maurizio Cirilli; Takashi Kobayashi; Nirupama K Shevde; Deena Segal; Oki K Dzivenu; Masha Vologodskaia; Mijung Yim; Khoi Du; Sujay Singh; J Wesley Pike; Bryant G Darnay; Yongwon Choi; Hao Wu
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

Authors:  Geng Wu; Guozhou Xu; Brenda A Schulman; Philip D Jeffrey; J Wade Harper; Nikola P Pavletich
Journal:  Mol Cell       Date:  2003-06       Impact factor: 17.970

10.  A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).

Authors:  Yin Lin; Jennifer Martin; Cornelia Gruendler; Jennifer Farley; Xianwang Meng; Bi-Yu Li; Robert Lechleider; Carla Huff; Richard H Kim; William A Grasser; Vishwas Paralkar; Tongwen Wang
Journal:  BMC Cell Biol       Date:  2002-06-21       Impact factor: 4.241

View more
  19 in total

Review 1.  Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.

Authors:  Fu Shang; Allen Taylor
Journal:  Mol Aspects Med       Date:  2012-04-10

2.  Ligand-switchable substrates for a ubiquitin-proteasome system.

Authors:  Emily L Egeler; Lorenz M Urner; Rishi Rakhit; Corey W Liu; Thomas J Wandless
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

3.  Targeted chemical-genetic regulation of protein stability in vivo.

Authors:  Susana Rodriguez; Michael J Wolfgang
Journal:  Chem Biol       Date:  2012-03-23

Review 4.  Ubiquitin-proteasome pathway and cellular responses to oxidative stress.

Authors:  Fu Shang; Allen Taylor
Journal:  Free Radic Biol Med       Date:  2011-04-08       Impact factor: 7.376

Review 5.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

Review 6.  Targeting proteins for degradation.

Authors:  Erin K Schrader; Kristine G Harstad; Andreas Matouschek
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

7.  Alg13p, the catalytic subunit of the endoplasmic reticulum UDP-GlcNAc glycosyltransferase, is a target for proteasomal degradation.

Authors:  Nicole Averbeck; Xiao-Dong Gao; Shin-Ichiro Nishimura; Neta Dean
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

8.  The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.

Authors:  Yuhua Wang; Emmanuel Tadjuidje; Ram Naresh Pandey; James A Stefater; Lois E H Smith; Richard A Lang; Rashmi S Hegde
Journal:  Am J Pathol       Date:  2016-01-05       Impact factor: 4.307

9.  In vivo imaging, tracking, and targeting of cancer stem cells.

Authors:  Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

10.  Substrate selection by the proteasome during degradation of protein complexes.

Authors:  Sumit Prakash; Tomonao Inobe; Ace Joseph Hatch; Andreas Matouschek
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.